These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


662 related items for PubMed ID: 16909121

  • 1. Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor.
    An J, Chervin AS, Nie A, Ducoff HS, Huang Z.
    Oncogene; 2007 Feb 01; 26(5):652-61. PubMed ID: 16909121
    [Abstract] [Full Text] [Related]

  • 2. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells.
    Drew L, Fine RL, Do TN, Douglas GP, Petrylak DP.
    Clin Cancer Res; 2002 Dec 01; 8(12):3922-32. PubMed ID: 12473608
    [Abstract] [Full Text] [Related]

  • 3. Proton induces apoptosis of hypoxic tumor cells by the p53-dependent and p38/JNK MAPK signaling pathways.
    Lee KB, Kim KR, Huh TL, Lee YM.
    Int J Oncol; 2008 Dec 01; 33(6):1247-56. PubMed ID: 19020758
    [Abstract] [Full Text] [Related]

  • 4. Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL.
    Hsu WH, Hsieh YS, Kuo HC, Teng CY, Huang HI, Wang CJ, Yang SF, Liou YS, Kuo WH.
    Arch Toxicol; 2007 Oct 01; 81(10):719-28. PubMed ID: 17673978
    [Abstract] [Full Text] [Related]

  • 5. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase.
    Singh SV, Choi S, Zeng Y, Hahm ER, Xiao D.
    Cancer Res; 2007 Aug 01; 67(15):7439-49. PubMed ID: 17671214
    [Abstract] [Full Text] [Related]

  • 6. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP.
    Engedal N, Korkmaz CG, Saatcioglu F.
    Oncogene; 2002 Feb 07; 21(7):1017-27. PubMed ID: 11850819
    [Abstract] [Full Text] [Related]

  • 7. Dicoumarol potentiates cisplatin-induced apoptosis mediated by c-Jun N-terminal kinase in p53 wild-type urogenital cancer cell lines.
    Watanabe J, Nishiyama H, Matsui Y, Ito M, Kawanishi H, Kamoto T, Ogawa O.
    Oncogene; 2006 Apr 20; 25(17):2500-8. PubMed ID: 16518417
    [Abstract] [Full Text] [Related]

  • 8. Chronic high-dose morphine treatment promotes SH-SY5Y cell apoptosis via c-Jun N-terminal kinase-mediated activation of mitochondria-dependent pathway.
    Lin X, Wang YJ, Li Q, Hou YY, Hong MH, Cao YL, Chi ZQ, Liu JG.
    FEBS J; 2009 Apr 20; 276(7):2022-36. PubMed ID: 19292871
    [Abstract] [Full Text] [Related]

  • 9. Triptolide induces Bcl-2 cleavage and mitochondria dependent apoptosis in p53-deficient HL-60 cells.
    Wan CK, Wang C, Cheung HY, Yang M, Fong WF.
    Cancer Lett; 2006 Sep 08; 241(1):31-41. PubMed ID: 16316721
    [Abstract] [Full Text] [Related]

  • 10. Plumbagin (5-hydroxy-2-methyl-1,4-naphthoquinone) induces apoptosis and cell cycle arrest in A549 cells through p53 accumulation via c-Jun NH2-terminal kinase-mediated phosphorylation at serine 15 in vitro and in vivo.
    Hsu YL, Cho CY, Kuo PL, Huang YT, Lin CC.
    J Pharmacol Exp Ther; 2006 Aug 08; 318(2):484-94. PubMed ID: 16632641
    [Abstract] [Full Text] [Related]

  • 11. Norepinephrine induces apoptosis in neonatal rat endothelial cells via a ROS-dependent JNK activation pathway.
    Fu YC, Yin SC, Chi CS, Hwang B, Hsu SL.
    Apoptosis; 2006 Nov 08; 11(11):2053-63. PubMed ID: 17041759
    [Abstract] [Full Text] [Related]

  • 12. Diallyl trisulfide-induced apoptosis in human prostate cancer cells involves c-Jun N-terminal kinase and extracellular-signal regulated kinase-mediated phosphorylation of Bcl-2.
    Xiao D, Choi S, Johnson DE, Vogel VG, Johnson CS, Trump DL, Lee YJ, Singh SV.
    Oncogene; 2004 Jul 22; 23(33):5594-606. PubMed ID: 15184882
    [Abstract] [Full Text] [Related]

  • 13. Melatonin induces apoptotic death in LNCaP cells via p38 and JNK pathways: therapeutic implications for prostate cancer.
    Joo SS, Yoo YM.
    J Pineal Res; 2009 Aug 22; 47(1):8-14. PubMed ID: 19522739
    [Abstract] [Full Text] [Related]

  • 14. Mechanism of synergy of N-(4-hydroxyphenyl)retinamide and ABT-737 in acute lymphoblastic leukemia cell lines: Mcl-1 inactivation.
    Kang MH, Wan Z, Kang YH, Sposto R, Reynolds CP.
    J Natl Cancer Inst; 2008 Apr 16; 100(8):580-95. PubMed ID: 18398104
    [Abstract] [Full Text] [Related]

  • 15. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer.
    Maeda H, Hori S, Nishitoh H, Ichijo H, Ogawa O, Kakehi Y, Kakizuka A.
    Cancer Res; 2001 Jul 15; 61(14):5432-40. PubMed ID: 11454688
    [Abstract] [Full Text] [Related]

  • 16. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
    Hu H, Jiang C, Ip C, Rustum YM, Lü J.
    Clin Cancer Res; 2005 Mar 15; 11(6):2379-88. PubMed ID: 15788689
    [Abstract] [Full Text] [Related]

  • 17. Requirement of the JNK-associated Bcl-2 pathway for human lactoferrin-induced apoptosis in the Jurkat leukemia T cell line.
    Lee SH, Park SW, Pyo CW, Yoo NK, Kim J, Choi SY.
    Biochimie; 2009 Jan 15; 91(1):102-8. PubMed ID: 18534198
    [Abstract] [Full Text] [Related]

  • 18. Involvement of Bcl-2 family members, phosphatidylinositol 3'-kinase/AKT and mitochondrial p53 in curcumin (diferulolylmethane)-induced apoptosis in prostate cancer.
    Shankar S, Srivastava RK.
    Int J Oncol; 2007 Apr 15; 30(4):905-18. PubMed ID: 17332930
    [Abstract] [Full Text] [Related]

  • 19. Roles of p38- and c-jun NH2-terminal kinase-mediated pathways in 2-methoxyestradiol-induced p53 induction and apoptosis.
    Shimada K, Nakamura M, Ishida E, Kishi M, Konishi N.
    Carcinogenesis; 2003 Jun 15; 24(6):1067-75. PubMed ID: 12807754
    [Abstract] [Full Text] [Related]

  • 20. HA14-1 sensitizes TNF-alpha-induced apoptosis via inhibition of the NF-kappaB signaling pathway: involvement of reactive oxygen species and JNK.
    Moon DO, Kim MO, Kang SH, Choi YH, Park SY, Kim GY.
    Cancer Lett; 2010 Jun 01; 292(1):111-8. PubMed ID: 20022690
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 34.